Cancer Genomics: Deciphering Risk and Driving Discovery

Available On Demand

Cancer has long been recognized as a genetic disease, from the discoveries of oncogenes and tumor suppressors, to hypothesis-driven work in model organisms. In recent years, scientists have been able to explore with unprecedented depth the genetic variation and mutational processes that promote tumor formation, progression, and evolution. In this AJHG-Cell Press Webinar, Stephen Chanock (National Cancer Institute), Kate Nathanson (University of Pennsylvania), and Peter Campbell (Wellcome Sanger Institute), will explore the ways in which genomic technology has transformed cancer research, leading to new biological insights and revolutionizing clinical practice.

Stephen Chanock
Director, Division of Cancer Epidemiology & Genetics
National Cancer Institute, National Institutes of Health
View Biography
Kate Nathanson
Pearl Basser Professor for BRCA-Related Research
Department of Medicine,
Translational Medicine & Human Genetics
Perelman School of Medicine, University of Pennsylvania
Deputy Director, Abramson Cancer Center
View Biography
Peter Campbell
Head of Cancer, Aging and Somatic Mutation
Senior Group Leader, Wellcome Trust Sanger Institute
View Biography
Moderator: Sara Cullinan
Deputy Editor, The American Journal of Human Genetics

Registration Details:

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)